Evaluation of Pharmacokinetic and Pharmacodynamic Interactions when Lenalidomide is Co-administered with Warfarin in a Randomized Clinical Trial Setting
Crossref DOI link: https://doi.org/10.1007/s40261-015-0299-1
Published Online: 2015-05-30
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weiss, Daniel
Knight, Robert
Zhou, Simon
Palmisano, Maria
Chen, Nianhang
Funding for this research was provided by:
Celgene Corporation
Text and Data Mining valid from 2015-05-30